Wie hoch ist der Preis für Stratec SE (SBS)

Preis für Stratec SE (SBS) ist $30.07

Wie hoch ist die Marktkapitalisierung für Stratec SE (SBS)

Marktkapitalisierung für Stratec SE (SBS) ist $365.52M

Stratec SE (SBS) Gewinne

Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.

Jahr	Gewinn	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Gewinn

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Gewinn	Gewinnunterschied	Land
Abbott Laboratories ABT.US	$7.51B	-	US
Stryker Corporation SYK.US	$5.15B	-	US
Medtronic plc MDT.US	$5.56B	-	IE
Boston Scientific Corporation BSX.US	$3.86B	-	US
Edwards Lifesciences Corporation EW.US	$1.42B	-	US

Unternehmen

Gewinn

Gewinnunterschied

Land